Summary: FGEN stock was crushed last week on strong votes against Roxadustat in both DD and NDD by FDA AdComm Big-Mover event In battle...

Summary: FGEN stock has been on a long-term downward cycle since peaking in 2018, mainly because of complications/miscommunications...

Congrats to CARA on a well-executed and positive Phase 3 trial of KORSUVA injection for reduction of pruritis (severe itching) in...